|
Real-time Estimate
Cboe BZX
12:49:56 19/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 25.82 USD | -3.73% |
|
+24.35% | - |
| 09:43pm | BlossomHill Therapeutics Q2 Loss Widens | MT |
| 09:14pm | Earnings Flash (BLSM) BlossomHill Therapeutics Posts Q2 Loss $8.75 a Share | MT |
Company Valuation: BlossomHill Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2026 | 2027 | 2028 |
|---|---|---|---|
| Market Cap 1 | 821.9 | - | - |
| Change | - | - | - |
| Enterprise Value (EV) | 821.9 | 821.9 | 821.9 |
| Change | - | 0% | 0% |
| P/E | -7.01x | -8.15x | -7.72x |
| PBR | - | - | - |
| PEG | 0.3x | 0.6x | -1.37x |
| Capitalization / Revenue | - | - | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | -7.34x | -6.04x | -5.17x |
| EV / EBIT | -7.76x | -6.32x | -5.09x |
| EV / FCF | -8.79x | -7.27x | -8.61x |
| FCF Yield | -11.4% | -13.7% | -11.6% |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -3.824 | -3.289 | -3.474 |
| Distribution rate | - | - | - |
| Net sales 1 | - | - | - |
| EBITDA 1 | -112 | -136 | -159 |
| EBIT 1 | -106 | -130.1 | -161.5 |
| Net income 1 | -101.2 | -121.4 | -153.4 |
| Net Debt | - | - | - |
| Reference price 2 | 26.82 | 26.82 | 26.82 |
| Nbr of stocks (in thousands) | 30,644 | - | - |
| Announcement Date | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.01x | - | - | - | 822M | ||
| 31.85x | 5.73x | 17.17x | 1.02% | 46.18B | ||
| 34.7x | 3.34x | 14.42x | -.--% | 44.35B | ||
| -20.15x | 232.19x | -21.56x | -.--% | 42.21B | ||
| 46.3x | 5.35x | 29.28x | -.--% | 40.19B | ||
| 27.32x | 7.86x | 20.08x | 0.42% | 29.83B | ||
| 34.98x | 5.74x | 26.08x | -.--% | 17.17B | ||
| 25.63x | 2.2x | 9.55x | 1.04% | 15.32B | ||
| 28.8x | 1.89x | 11.64x | -.--% | 13.09B | ||
| Average | 22.49x | 33.04x | 13.33x | 0.31% | 27.68B | |
| Weighted average by Cap. | 24.88x | 43.57x | 12.26x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BLSM Stock
- Valuation BlossomHill Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















